newsfilter
← Latest News
GlobeNewswire·

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

TORONTO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX:REUN, NASDAQ:REUN) ("Reunion" or the "Company"), a leader in novel serotonergic psychedelic drug development committed to innovating